https://www.selleckchem.com/pr....oducts/ch5183284-deb
To date, various inhibitors targeting KATs and KDACs have been discovered, and some of these inhibitors exert their anti-tumor activity via blocking Wnt/β-catenin signaling. Here, we discuss the available evidence in understanding the complicated interaction of protein lysine acetylation with Wnt/β-catenin signaling, and lysine acetylation as a new target for cancer therapy via controlling this signaling. Early start of highly active antiretroviral therapy (HAART) in perinatally HIV-1 infected children is the optimal strate
Like
Comment
Share
